Loading
Standard Perioperative Care / Digital Home-Based Prehabilitation / Thoracic Surgery · Interventional Study
ClinicalTrials.gov · September 9, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a prospective, single-centre randomized controlled trial comparing home-based prehabilitation using wearable devices to standard care in older adults (65–85 years) with NSCLC awaiting curative lung resection. No results have been posted; the trial is recruiting and outcome data are not yet available for clinical interpretation.
Interventional, Randomized, Parallel, Single masking, Treatment purpose. Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery, Prehabilitation; age from 65 Years; to 85 Years. Intervention: Wearable-Based Home Prehabilitation. Compared with: Standard Perioperative Care — Active Comparator. n = 196. 1 site: China.
This is a prospective, single-centre randomized controlled trial comparing home-based prehabilitation using wearable devices to standard care in older adults (65–85 years) with NSCLC awaiting curative lung resection. No results have been posted; the trial is recruiting and outcome data are not yet available for clinical interpretation.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a clinical trial registration with no reported results; the study is actively recruiting and outcome data are not yet available for analysis.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07809763). This is a study registration, not published results. Lead sponsor: West China Hospital. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 196 participants (ESTIMATED). Conditions: Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery, Prehabilitation. Interventions: BEHAVIORAL: Digital Home-Based Prehabilitation; BEHAVIORAL: Standard Perioperative Care. Primary outcome measures: FEV₁% Predicted at 90 Days Post-Surgery , 90 days after surgery (±14 days). Brief summary: This randomized controlled trial evaluates the efficacy and safety of a home-based prehabilitation program using wireless wearable monitoring devices in older patients (aged 65-85 years) with non-small cell lung cancer scheduled for curative lung resection. Participants are randomized 1:1 to either the intervention group, receiving a personalized exercise regimen (aerobic, resistance, and inspiratory muscle training) with continuous remote monitoring of steps, heart rate, and SpO₂ from 2-4 weeks preoperatively through 90 days postoperatively, or the control group receiving standard perioperative care. The primary endpoint is the between-group difference in FEV₁% predicted at 90 days post-surgery, adjusted for baseline. Secondary endpoints include functional capacity (6-minute walk distance), daily physical activity, hypoxemic burden (time with SpO₂\<90%, nocturnal oxygen desaturation index), patient-reported outcomes (EORTC QLQ-C30/LC13, mMRC), postoperative complications, readmission rates, days alive and at home, and safety outcomes. The target sample size is 198 participants enrolled at West China Hospital of Sichuan University. Anticipated risks include exercise-related musculoskeletal strain, fatigue, and transient cardiopulmonary symptoms, as well as mild skin reactions from devices, all managed through individualized exercise prescriptions, remote safety thresholds, and a graded response protocol.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.